Scabies Detected by Molecular Methods in Skin Scrapings
By LabMedica International staff writers Posted on 29 Apr 2020 |
Image: The LightCycler 96 Instrument is a real-time PCR system for rapid cycling up to 96 samples (Photo courtesy of Roche Molecular Systems).
Scabies caused by Sarcoptes scabiei mites, is a highly contagious parasitic disease characterized by intense itching which is aggravated at night. Infections by scabies mites result in various skin eruptions consisting of papules, nodules, vesicles, and excoriated eczematous lesions due to scratching.
Scabies is associated with long-term residence in nursing homes, the homeless and refugees, and it is a public health burden worldwide Microscopic examination of skin scrapings is widely used for the diagnosis of scabies, but it has a suboptimal sensitivity of only 50%. Dermoscopy has been widely used, but it has a disadvantage in that it has low specificity and is affected by the dermatologist’s experience.
Infectious disease specialists at the University of Ulsan College of Medicine (Seoul, Republic of Korea) evaluated the diagnostic value of polymerase chain reaction (PCR) from skin scraping in patients with suspected scabies. Adult patients with suspected scabies, unrelated diseases or healthy volunteers were enrolled at a tertiary hospital, from December 2017 through October 2018. A total of 47 participants, 33 with suspected scabies, 10 with unrelated diseases, and four healthy volunteers were enrolled. Of the 33 patients, 22 were classified as confirmed scabies, two as clinical scabies, six as suspected scabies, and three as no scabies. PCR was performed on the skin scrapings to target the cytochrome c oxidase subunit 1 (cox1) gene of Sarcoptes scabiei. Real-time PCR amplification was performed with the LightCycler 96 system (Roche Molecular Systems, Pleasanton, CA, USA).
The team reported that the sensitivities of the microscopic examination were 100%, 92%, and 73% in confirmed scabies; confirmed and clinical scabies; and confirmed, clinical, and suspected scabies, respectively. The sensitivities of PCR were 86%, 83%, and 80% in confirmed scabies; confirmed and clinical scabies; and confirmed, clinical, and suspected scabies, respectively. The specificity of the scabies PCR in the no scabies control was 100%. Of the 30 patients with scabies, five (17%) revealed negative results for microscopic examination, but positive results for scabies PCR.
The authors concluded that scabies PCR was shown to offer an improvement in assay sensitivity compared to that of microscopy examination for the diagnosis of scabies by clinical criteria. This technique can, therefore, be considered as an adjunct method for the diagnosis of scabies, particularly in microscopy-negative suspected cases. The study was published on April 7, 2020 in the journal PLOS Neglected Tropical Diseases.
Scabies is associated with long-term residence in nursing homes, the homeless and refugees, and it is a public health burden worldwide Microscopic examination of skin scrapings is widely used for the diagnosis of scabies, but it has a suboptimal sensitivity of only 50%. Dermoscopy has been widely used, but it has a disadvantage in that it has low specificity and is affected by the dermatologist’s experience.
Infectious disease specialists at the University of Ulsan College of Medicine (Seoul, Republic of Korea) evaluated the diagnostic value of polymerase chain reaction (PCR) from skin scraping in patients with suspected scabies. Adult patients with suspected scabies, unrelated diseases or healthy volunteers were enrolled at a tertiary hospital, from December 2017 through October 2018. A total of 47 participants, 33 with suspected scabies, 10 with unrelated diseases, and four healthy volunteers were enrolled. Of the 33 patients, 22 were classified as confirmed scabies, two as clinical scabies, six as suspected scabies, and three as no scabies. PCR was performed on the skin scrapings to target the cytochrome c oxidase subunit 1 (cox1) gene of Sarcoptes scabiei. Real-time PCR amplification was performed with the LightCycler 96 system (Roche Molecular Systems, Pleasanton, CA, USA).
The team reported that the sensitivities of the microscopic examination were 100%, 92%, and 73% in confirmed scabies; confirmed and clinical scabies; and confirmed, clinical, and suspected scabies, respectively. The sensitivities of PCR were 86%, 83%, and 80% in confirmed scabies; confirmed and clinical scabies; and confirmed, clinical, and suspected scabies, respectively. The specificity of the scabies PCR in the no scabies control was 100%. Of the 30 patients with scabies, five (17%) revealed negative results for microscopic examination, but positive results for scabies PCR.
The authors concluded that scabies PCR was shown to offer an improvement in assay sensitivity compared to that of microscopy examination for the diagnosis of scabies by clinical criteria. This technique can, therefore, be considered as an adjunct method for the diagnosis of scabies, particularly in microscopy-negative suspected cases. The study was published on April 7, 2020 in the journal PLOS Neglected Tropical Diseases.
Latest Molecular Diagnostics News
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection
- Single Genetic Test to Accelerate Diagnoses for Rare Developmental Disorders